Navigation Links
PA Health Department Suggests Measures to Reduce the Spread of 'MRSA'
Date:10/19/2007

ecently been in a heath care setting. This community-associated MRSA is most commonly seen among sports teams, in schools, prisons, military facilities and other places where there is frequent skin-to-skin contact. The sharing of towels and personal hygiene items like razors, athletic equipment, clothing and drug paraphernalia also promotes the spread of staph bacteria.

On the skin, community-associated MRSA usually appears as a pimple, boil or abscess that is red, swollen, painful, and may have pus or other drainage. Patients may think early signs of infection look like a spider bite or ingrown hair. It is important for anyone who has these symptoms to see a doctor because, if untreated, MRSA can lead to more serious infections.

Governor Rendell's "Prescription for Pennsylvania" health care reform initiative established Pennsylvania as a national leader in the effort to track and prevent MRSA and other infections in health care settings.

The Governor recently signed Act 52, which requires hospitals and nursing homes to report health care associated infections, and for hospitals, nursing homes and ambulatory surgical facilities to implement comprehensive infection control plans to stop its spread. Details are available at http://www.rxforpa.com.

For more information about MRSA, visit http://www.health.state.pa.us or call 1-877-PA-HEALTH.

CONTACT:

Stacy Kriedeman

(717) 787-1783


'/>"/>
SOURCE Pennsylvania Department of Health
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Startling Expose – Physicians Often Have No Regular Source Of Health Car
3. Debate Rages over firing of HIV infected health care workers
4. Want a Healthy brew? Have some Tea!
5. Patient’s perception of health status helps in better recover
6. Antioxidants protect health tissue in people undergoing radiation therapy.
7. Sexual abuse affect health for a lifetime
8. Smoking a greater risk than HIV? Yes say health experts!!!!
9. Healthcare sector is now a multi billion-dollar industry in India
10. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
11. How much can exercise improve health?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...t. Jude Children,s Research Hospital have demonstr...monia following influenza. They found that the ant...bacteria by inhibiting their protein synthesis, ar...ent with the "beta-lactam" antibiotic ampicillin, ... The finding is important because pneumonia, rathe...
(Date:1/8/2009)..., Jan. 8 Hanger Orthope...nce that throughout the fourth quarter of 2008 it ...er, Rocky Mountain Orthotic-Prosthetics Center, Ri...First Coast Orthotics & Prosthetics, and Ortho...ions add patient care centers to existing markets ...
(Date:1/8/2009)...ed Acquisition in 2009 Continues Growth Trend , ...stCall/ -- IPC The Hospitalist Company, Inc. (Nasd...cian group practice company, announced today that ...t Acute Care Consultants, Inc. (MACC) in St. Louis...xpansion in the St. Louis market, where IPC has es...
(Date:1/8/2009)... Md., Jan. 8 /PRNewswire-Asia/ -- Chindex Internat...pany"), a leading independent American,provider o...People,s Republic,of China, today announced that ...a Conference, to be held in Shanghai on January 12...onference will be held at the Pudong Shangri-,La ...
Breaking Medicine News(10 mins):Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2
...stem, will invest $20 million to establish the wor...India, to provide stem cells for transplant surgeo... a 10% equity stake in this venture and two seats ...nt guidelines are followed, Said company president...
...d occupy greater priority in India due to the ever...chewing practices. There has been a considerable i...n men. // In India and Sri Lanka, where chewing t...verse smoking is practiced, there is a striking in...
...s had a sensitive tooth at some point of their lif... tooth is worn out' or 'you brush in a hard way, s...the Leeds University have come out with a solution... memory. The researchers have developed a solution...
...fund a study which helps to understand the benefit... given to breast cancer patients to ease the pain ...es. The study is to be carried out by Researchers ...will be comparing the three complementary therapy ...
Other Medicine News:Health News:Dental health neglected by over 60 % of Indians 2
(Date:1/7/2009)...PRNewswire/ -- ImQuest Life Sciences announced tod... to the Food and Drug Administration to initiate h...e HIV inhibitor IQP-0410. ImQuest anticipates init...of 2009. IQP-0410 is a novel small molecule inhibi... reverse transcriptase inhibitor (NNRTI). The comp...
(Date:1/7/2009)...uary 7 Circassia Ltd, a specialty,...critical care, today,announced that following suc...s ToleroMune(R) anti-allergy technology, the compa...rther phase II clinical trial in cat allergy. The,... 120 patients with confirmed,cat allergies, and a...
(Date:1/6/2009)...RNewswire/ -- In recent controlled studies conduct..., scientists found that the patented ingredient in...y proven ingredient to increase levels of nitric o...trate/nitrate (NOx) in human subjects. , , Nitr...ease in blood flow to the skeletal muscles. This ...
(Date:1/6/2009)... Cequent Pharmaceuticals, a pionee...RNAi-based treatments to prevent and treat human d...mpleted a successful toxicology study of its candi...peutic targeting the primary oncogene (beta-cateni.... FAP is an inherited gastrointestinal disease tha...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 1Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 2Gene Activity May Explain Deadlier Breast Cancers Among Younger Women 23563 3China Medicine Releases White Paper on Developing Recombinant Aflatoxin Detoxifizyme 23558 1China Medicine Releases White Paper on Developing Recombinant Aflatoxin Detoxifizyme 23558 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 1Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 3Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 1Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 2Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 3Orexigen 28R 29 Initiates Second Phase IIb Empatic 28TM 29 Trial on Schedule 2602 4
...ETROIT, April 16, 2007 /PRNewswire/ -- Karmanos Ca... on two research,studies investigating racial disp... American Association of Cancer Research,annual me...h endometrial or ovarian cancer, on,average, live ...ed,by Veronica Schimp, D.O., assistant professor o...
...nespimycin Shown to Have No Effect on QTc Interval...Kosan,Biosciences Incorporated today presented saf...its lead Hsp90 inhibitor,tanespimycin (KOS-953). ...nts was conducted in four Phase 1 trials of tanesp... in more than 85,patients. Tanespimycin was found ...
Other Medicine Technology:Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 2Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 2Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 4
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: